Risks tied to this specific entity.
No issues detected across 7 sources
No issues detected across 1 source
Ingredion appears to have lost significant market position or operational control in Pakistan's corn sector to competitor Nishat, indicating supply chain and competitive risks in a key sourcing region.
Tate & Lyle's £2.7bn acquisition by a US competitor signals material industry consolidation affecting Ingredion's competitive landscape and supply chain dynamics.
Ingredion's merger with Tate & Lyle represents a major market consolidation event with potential supply chain restructuring, integration risks, and customer impact implications.
Major consolidation in the corn refining/ingredient supply sector through a potential £2.7bn takeover could reshape market dynamics and supply chain relationships affecting Ingredion's competitive environment and customer/supplier relationships.
Ingredion's recommended cash acquisition of Tate & Lyle PLC presents high supply chain risk severity due to integration complexity, operational consolidation requirements, and potential disruptions during the transaction.
Ingredion's £2.7bn acquisition of Tate & Lyle represents a major corporate consolidation event with significant supply chain and operational integration risks.
Ingredion's acquisition of Tate & Lyle presents moderate supply chain risk due to potential integration challenges and consolidation impacts in the specialty ingredients sector.
Ingredion's acquisition offer for Tate & Lyle represents a significant corporate transaction with potential supply chain integration, operational, and regulatory risks requiring monitoring.
Ingredion's £2.7bn acquisition of Tate & Lyle has received shareholder backing, creating medium-severity supply chain integration and operational execution risks.
Ingredion's acquisition of Tate & Lyle creates integration risks and supply chain consolidation effects requiring monitoring during transition.
Ingredion's £2.7 billion acquisition of Tate & Lyle represents a major corporate transaction with potential supply chain integration risks and competitive market implications.
Ingredion Q2 earnings analysis indicating margin pressures in key business segments, suggesting potential supply chain cost inflation or operational efficiency challenges.
Ingredion's acquisition of Tate & Lyle represents a material corporate restructuring event with moderate supply chain risk due to integration complexities and potential operational changes.
Ingredion's acquisition of Tate & Lyle presents medium supply chain risk due to potential integration complexities and operational disruption during the consolidation process.
Ingredion's acquisition of Tate & Lyle represents a major supply chain consolidation event with potential integration, operational, and market competition implications.
Ingredion's acquisition of Tate & Lyle represents a significant consolidation in the ingredients supply sector with moderate integration and market concentration risks.
Ingredion's proposed all-cash acquisition of Tate & Lyle represents a significant supply chain and operational integration risk requiring monitoring of post-merger execution.
Ownership change clarification at Ingredion's Rafhan Maize subsidiary in Pakistan presents medium supply chain risk due to potential governance and operational implications in a key regional manufacturing facility.
Ingredion's $3.7 billion acquisition bid for Tate & Lyle represents a significant industry consolidation with potential supply chain integration risks and market concentration implications.
Ingredion's $3.7 billion acquisition bid for Tate & Lyle represents a material supply chain consolidation event requiring assessment of integration risks and market impact.
Ingredion's acquisition offer for Tate & Lyle presents medium supply chain risk due to integration complexity, operational consolidation, and potential market concentration concerns.
Ingredion's major acquisition attempt of Tate & Lyle introduces integration risks, market consolidation effects, and potential supply chain disruption during the merger process.
Ingredion is reassessing its business operations in response to surge in product reformulations by customers, indicating potential supply chain demand volatility and need for operational adaptation.
Ingredion missed Q3 2025 revenue estimates, indicating potential demand or operational challenges that could impact ingredient supply reliability.
markets.financialcontent.com: FinancialContent - INGR Q2 Deep Dive : Texture & Healthfu...; manilatimes.net: Ingredion 595 pence All - Cash Offer to Acquire Tate & Ly...; finanznachrichten.de: Ingredion Incorporated : Ingredion 595 pence All - Cash O...
GDELTNo issues detected across 2 sources
Top origins: Thailand, China, Singapore. Period: 2023-09-01 to 2026-09-01
ImportYeti (US Customs)No issues detected across 1 source
Penalties: $99000. Quarters non-compliant: 12. Programs: CAA, CWA, RCRA
Penalties: $80000. Quarters non-compliant: 6. Programs: CAA, CWA, RCRA
Penalties: $3000. Quarters non-compliant: 8. Programs: CAA, CWA, RCRA
Penalties: $0. Quarters non-compliant: 5. Programs: CAA, CWA, RCRA
Penalties: $5500. Quarters non-compliant: 0. Programs: CAA, CWA, RCRA
Penalties: $2450. Quarters non-compliant: 0. Programs: CAA, CWA, RCRA
INGREDION INCORPORATED: 12 qtrs non-compliance, $99000 penalties; INGREDION INCORPORATED: 8 qtrs non-compliance, $80000 penalties; INGREDION INC: 5 qtrs non-compliance, $0 penalties
EPA ECHORisks tied to the location of this facility.
Political stability: 0.03, Rule of law: 1.33, Corruption control: 1.12
World Bank WGI 2023No issues detected across 2 sources
Salmonella Infantis in poultry is directly relevant to Ingredion's supply chain as poultry-derived ingredients (gelatin, collagen, flavors) and cross-contamination risks in shared facilities could compromise product safety and trigger recalls.
Measles outbreaks across multiple US states could disrupt Ingredion's workforce availability and operations through employee illness, quarantine requirements, and potential facility closures, though the disease poses no direct threat to product safety or raw materials.
PROMED alert in United States: measles
PROMED alert in United States: measles
PROMED alert in United States: measles
PROMED alert in United States: measles
PROMED alert in United States: salmonella
PROMED alert in United States: measles
PROMED alert in United States: measles
PROMED alert in United States: botulism
PROMED alert in United States: measles
PROMED alert in United States: measles
PROMED alert in United States: influenza
PROMED alert in United States: measles
PROMED alert in United States: measles
E. COLI EHEC - USA (13): (FLORIDA, GEORGIA) ex CHILE, O145:H28, FROZEN BLUEBERRIES; AVIAN INFLUENZA - USA (26): (SOUTH DAKOTA) COMMERCIAL POULTRY, HPAI H5N1; EASTERN EQUINE ENCEPHALITIS - USA (07): (WISCONSIN, MICHIGAN) HORSE
WHO/CDC/ProMED